CompletedEarly Phase 1

Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial

United Kingdom22 participantsStarted 2013-02

Plain-language summary

The purpose of this study was to test the effect of chronic consumption of Quercetin 500 mg tablets on blood uric acid and other biomarkers in adult males.

Who can participate

Age range19 Years – 65 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Written informed consent * Plasma Uric Acid \> 300 micro Mole/L * Generally Healthy Exclusion Criteria: * Body Mass Index (BMI) ≥ 30 kg/m² or \<18.5 kg/m² * Unable or unwilling to comply with the protocol, or likely to leave the study before its completion. * Who would undertake important change in physical exercise or vigorous sport competitions during the study period. * regularly drink more than 3 units of alcohol every day * smokers * have history of treated hyperuricemia, gout and/ or kidney stone * have intestinal disorders

What they're measuring

Risk of getting hyperuricemia assessed by the measure of plasma uric acid.

Timeframe: Fasting blood samples are taken on day 1, day 15 and day 29 of each arm

Trial details

NCT IDNCT01881919

SponsorUniversity of Leeds

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-04

View on ClinicalTrials.gov More Hyperuricemia trials